Tag Archives: M42

Health Care

M42’s Strategy Enhances Access to Kidney Treatment in Brazil

  • Expansion strengthens Diaverum’s footprint in Brazil with 18 clinics and 3 vascular access centers
  • Growing footprint tackles chronic kidney disease, a public health issue, with over 220,000 treatments annually
  • Acquisition underpins M42’s strategy to build globally connected care platforms to improve access to high-quality care in line with data sovereignty regulations

Abu Dhabi, UAE – 23 April 2026: M42, a global health leader powered by AI, technology and genomics, and its world leading renal care business, Diaverum, today announced the completion of a strategic acquisition of four clinics in the state of São Paulo, Brazil, from the Lund Group: CDTR and CDTR Prime in Sorocaba, INDI in Itapetininga, and Lund Nefrologia in Itu. The move takes Diaverum clinics to 18 in Brazil, including three vascular access centers, affirming its long-term commitment to improving access to renal care and supporting better health outcomes in Latin America’s largest market.

Continue reading M42’s Strategy Enhances Access to Kidney Treatment in Brazil →
Health Care

M42 Announces Strategic Investment and Partnership with Leading Biotech Juvenescence

  • M42 and Juvenescence will collaborate in drug discovery to develop a pipeline of innovative medicines to advance the prevention and treatment of diseases of high unmet need within UAE and globally and age-related diseases
  • The strategic partnership aligns with M42’s newly launched AI Life Sciences Platform
  • M42’s strategic investment in Juvenescence will accelerate Juvenescence’s clinical pipeline and drug development capabilities which underscores this collaboration
  • Expansion of capabilities in AI-enabled therapeutics underlines Abu Dhabi’s vision of becoming a global hub for AI-driven longevity science and next-generation drug development
Continue reading M42 Announces Strategic Investment and Partnership with Leading Biotech Juvenescence →
Health Care

DoH, M42, PureHealth, Illumina, NYUAD, KU and IHLAD launch strategic partnership

As part of Abu Dhabi’s efforts to enhance patient outcomes,

DoH, M42, PureHealth, Illumina, NYUAD, KU and IHLAD launch strategic partnership to advance precision medicine in the Emirate

  • DoH, PureHealth, Khalifa University, Illumina, M42, IHLAD and New York University Abu Dhabi have signed a landmark MoU to establish a collaborative framework that will shape the future of healthcare through precision medicine and advanced therapies
  • The multi-stakeholder partnership will drive genomic innovation, AI-powered healthcare, and local talent development through cutting-edge research and clinical integration
Continue reading DoH, M42, PureHealth, Illumina, NYUAD, KU and IHLAD launch strategic partnership →
Health Care

M42 to lead strategic discussions on genomics, artificial intelligence, preventive healthcare and precision medicine at Arab Health 2025

  • Global health leader aims to drive forward sustainable healthcare practices and meaningful collaborations at the 50th edition of the global exhibition
  • Prevention must be at the core of every healthcare strategy and collaboration is key to achieving this vision – M42’s Managing Director and Group Chief Executive Officer
  • Cleveland Clinic in the U.S., Cleveland Clinic London and Cleveland Clinic Abu Dhabi experts to advance important Continuing Medical Education (CME) conferences that will share insights on topics such as robotic surgery, artificial intelligence, genomics and advances in cancer prevention, screening and treatment

Abu Dhabi, UAE, 21 January 2025: M42, a global health leader powered by artificial intelligence (AI) and technology, is set to lead conversations and debates on the critical areas for local and international collaboration to support global progress in healthcare at Arab Health 2025. As the Global Health Partner at the event, M42’s Managing Director and Group Chief Executive Officer, Hasan Jasem Al Nowais, said thatM42’s global health leadership sees it being at the forefront of initiatives that revolutionize healthcare and help create a healthier, more equitable world. In a world where nations are facing rising healthcare costs, mounting pressures on health systems, and rising incidences of disease, he emphasized the urgent need to shift from reactive to preventive care models and come together to plug the global healthcare gaps.

Continue reading M42 to lead strategic discussions on genomics, artificial intelligence, preventive healthcare and precision medicine at Arab Health 2025 →
Featured

National Multiple Sclerosis Society Teams Up with M42 to Launch MS Helpline in the UAE

  • The “MS Helpline” facilitates access to resources and assists people living with multiple sclerosis to find the most suitable treatment facilities
  • The service is offered daily from 10:00 AM to 10:00 PM in its initial phase
  • The MS Helpline is supported by the Mubadala Foundation and operated by M42

Abu Dhabi, 10 December 2024 — The National Multiple Sclerosis Society (NMSS) has launched the “MS Helpline,” a new service designed to provide information on specialist Multiple Sclerosis (MS) healthcare practitioners across the UAE. The helpline also offers active listening support and facilitates mental health assessments. It also serves as a data collection tool to build the NMSS’s database and enhance existing programs.

Continue reading National Multiple Sclerosis Society Teams Up with M42 to Launch MS Helpline in the UAE →